Rheumatology experts review history of LN, offer explanations for roadblocks to better therapies
Rheumatology Research Foundation Backs Need to Accelerate New Medicines for Lupus
Foundation appeals to Congressional lawmakers for support of biomedical innovation to battle lupus
The ACR President Joseph Flood, MD, Reviews 2014 in Rheumatology
Information technology an overarching theme of this year’s work
Antiphospholipid Antibodies Activate mTORC in Vessels
Research around autoimmune disorder shows patients may respond to treatment with sirolimus
Accelerating Medicines Partnership Targets Therapies for Rheumatoid Arthritis, Systemic Lupus Erythematosus
Research collaboration among scientists, pharmaceutical companies, nonprofits promotes precompetitive sharing of data collection, analyses
Autoimmune Myelofibrosis: A Case Review
Diagnosis, treatment and management of AMF in Hispanic patient with lupus
Rheumatology Drug Updates, Trials, Safety Data
An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid
Lupus Classification Criteria Expanded; Treat-to-Target Approach Gains Support
Rheumatologists at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco outline disease classification criteria, treat-to-target approach to lupus
The 2014 ACR/ARHP Annual Meeting Offers Programs for Rheumatology Clinicians, Researchers, Practice Management Professionals
Rheumatology’s premier event to be held in Boston from Nov. 14–19
How Rheumatologists Can Connect with Congressional Lawmakers during August Recess
Tips on scheduling in-office meetings in legislators’ home districts and which issues to discuss
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 19
- Next Page »